GlassScriptPhysician profile
Fernando Catalina
NPI 1528056892
$1,171.50
in general payments reported to CMS, 2019-2025
18 companies · $452 in 2025
The $452 reported for 2025 was more than what 92% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $39.27 · 2021: $97.18 · 2022: $152 · 2023: $212 · 2024: $219 · 2025: $452.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $883.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $883.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $158.86 | 2020-2025 | Bexsero, Fluarix Quadrivalent, Pediarix |
| Pfizer INC. | $158.79 | 2021-2025 | |
| Collegium Pharmaceutical, INC. | $139.03 | 2025 | Jornay Pm |
| Corium, LLC | $125.96 | 2023-2024 | Azstarys |
| Supernus Pharmaceuticals, INC. | $83.16 | 2022 | |
| Kaleo, INC. | $79.97 | 2020-2023 | Auvi-Q |
| Hologic Sales and Service, LLC | $60.31 | 2023-2024 | Aptima, Thinprep 2000 Processor |
| Sanofi-Aventis U.S. LLC | $52.24 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $49.14 | 2023-2025 | M-M-R II, Gardasil 9, Vaxelis |
| Cranial Technologies, INC | $46.22 | 2025 | Doc Band |
| Ars Pharmaceuticals Operations, INC. | $44.55 | 2025 | Neffy |
| Seqirus USA INC | $39.06 | 2022-2025 | Flucelvax |
| Vertical Pharmaceuticals, LLC | $38.11 | 2024-2025 | Relexxii |
| Biomarin Pharmaceutical INC. | $24.68 | 2024 | Voxzogo 1.2mg |
| Exeltis, USA INC. | $21.33 | 2024 | Slynd |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $20.61 | 2023 | Flumist Quadrivalent |
| Alk-Abello, INC | $14.80 | 2025 | Neffy |
| Sanofi Pasteur INC. | $14.68 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fernando Catalina listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.